{
    "clinical_study": {
        "@rank": "16509", 
        "arm_group": {
            "arm_group_label": "Diagnosis of CRC", 
            "arm_group_type": "Other", 
            "description": "All the patients enrolled received all the 3 procedures: capsule colonoscopy; CT-colonography and optical colonoscopy."
        }, 
        "brief_summary": {
            "textblock": "In this study the investigators evaluate the sensitivity of PCC2 (PillCam Colon Capsule 2\n      (R)) in identifying significant polyps in a CRC (Colo Recatal Cancer) screening program\n      (primary outcome measure).\n\n      Each enrolled patient underwent three procedures: colon capsule endoscopy, CT-colonography\n      and optical colonoscopy. In this study the reference standard is represented by the\n      segmental unblinded colonoscopy (the unblinding is based on results of both capsule\n      endoscopy and Ct colonography) The investigators also evaluated the tolerability of PCC2 as\n      compared to optical colonoscopy (OC) and CT-colonography (CTC)."
        }, 
        "brief_title": "PillCam Colon Capsule 2\u00ae (PCC2) in the Setting of Colorectal Cancer Screening Program", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Colon Cancer", 
        "condition_browse": {
            "mesh_term": [
                "Colonic Neoplasms", 
                "Colorectal Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "Asymptomatic average risk subjects with positive iFOBT (immunochemical Fecal Occult Blood\n      Test), participating the regional screening program, were offered to undergo PCC2 (PillCam\n      Colon Capsule 2 (R)) followed, 21 days later, by CTC and OC performed on the same day. The\n      number, size and location of significant polyps (>6mm) identified by each procedure were\n      compared with the reference standard (RS), which was represented by the segmental unblinded\n      colonoscopy. The unblinding was based on the integration of CTC and PCC2 results. For the\n      PPC2 the quality of the bowel preparation (adequate/inadequate) and the completeness of the\n      examination (capsule excreted still working or visualization of the anal verge) were also\n      reported. In order to evaluate the tolerability, each subject was asked to identify, among\n      the 3 procedures performed, which was the less tolerated one and which one he would be\n      willing to repeat."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  asymptomatic average risk subjects, participating the regional colon cancer screening\n             program, with positive iFOBT referred for colonoscopy\n\n        Exclusion Criteria:\n\n          -  presence of obstructive symptoms\n\n          -  swallowing disorders\n\n          -  presence of cardiac pacemaker"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "50 Years"
        }, 
        "enrollment": {
            "#text": "35", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01744509", 
            "org_study_id": "25-2011"
        }, 
        "intervention": {
            "arm_group_label": "Diagnosis of CRC", 
            "description": "All the enrolled patients underwent all the three study procedures; the colon capsule is the intervention under evaluation; the other 2 procedures (Ct colonography and optcal colonoscopy contribute to build the composite reference standard)", 
            "intervention_name": "Capsule colonoscopy;", 
            "intervention_type": "Device", 
            "other_name": "Capsule colonoscopy: PillCam Coln Capsule 2"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 5, 2012", 
        "location": {
            "contact": {
                "email": "gispinz@tin.it", 
                "last_name": "Giancarlo Spinzi, MD", 
                "phone": "0039031324145"
            }, 
            "facility": {
                "address": {
                    "city": "Como", 
                    "country": "Italy", 
                    "zip": "22100"
                }, 
                "name": "Ospedale Valduce"
            }, 
            "investigator": [
                {
                    "last_name": "Giancarlo Spinzi, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Emanuele Rondonotti, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Vittorio Terruzzi", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Franco Radaelli", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Silvia Paggi", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Arnaldo Amato", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Giovanna Mandelli", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Natalia Terreni", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Lenoci Nicoletta", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Gianni Imperiali", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Claudia Borghi", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Alberto Martegani", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "1", 
        "official_title": "PillCam Colon Capsule 2\u00ae (PCC2) in the Setting of Colorectal Cancer Screening (CRC) Program: Comparison With a New Integrated Reference Standard", 
        "overall_official": {
            "affiliation": "Gastroenterology Unit; Ospedale Valduce", 
            "last_name": "Giancarlo Spinzi", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The number, size and location of significant polyps (>6mm) identified by each procedure were compared with the reference standard (RS), which was represented by the segmental unblinded colonoscopy.", 
            "measure": "Sensitivity of PillCam Colon Capsule 2 (R) in identifying significant colonic polyps", 
            "safety_issue": "No", 
            "time_frame": "participants are followed for about 1 month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01744509"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Valduce Hospital", 
            "investigator_full_name": "Emanuele Rondonotti", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "In order to evaluate the tolerability, each subject was asked to identify, among the 3 procedures performed, which was the less tolerated one and which one he would be willing to repeat.", 
            "measure": "to evaluate the tolerability of PCC2 as compared to optical colonoscopy (OC) and CT-colonography (CTC).", 
            "safety_issue": "No", 
            "time_frame": "participants are followed for about 1 month"
        }, 
        "source": "Valduce Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Valduce Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2011", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "December 2012"
    }
}